Separate mechanisms act concurrently to shed and release the prion protein from the cell

Prion

Volumn 6, Issue 5, 2012, Pages 498-509

  Wik, Lotta ^a   Klingeborn, Mikael ^a,c   Willander, Hanna ^b   Linné, Tommy ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

cleavage; Exosomes; Extreme C terminal cleavage; Inhibitor; Prion; Shedding

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; METALLOPROTEINASE INHIBITOR; PRION PROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXTRACELLULAR SPACE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN SECRETION;

ANIMALS; CELL LINE; CELL MEMBRANE; CRICETINAE; EXOSOMES; KINETICS; METALLOPROTEASES; PRION DISEASES; PRIONS; PRPC PROTEINS;

EID: 84869814585     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.22588     Document Type: Article

References (43)

1. Stahl N, Borchelt DR, Hsiao K, Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987; 51:229-40; PMID:2444340; http://dx.doi.org/10.1016/0092-8674(87)90150-4.
2. Stahl N, Baldwin MA, Burlingame AL, Prusiner SB. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 1990; 29:8879-84; PMID:1980209; http://dx.doi.org/10.1021/ bi00490a001.
3. Harris DA. Cell biological studies of the prion protein. Curr Issues Mol Biol 1999; 1:65-75; PMID:11475702.
4. Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339-47; PMID:8100741; http://dx.doi.org/10.1016/0092-8674(93)90360-3.
5. Zhao H, Klingeborn M, Simonsson M, Linné T. Proteolytic cleavage and shedding of the bovine prion protein in two cell culture systems. Virus Res 2006; 115:43-55; PMID:16140411; http://dx.doi.org/10.1016/j.virusres.2005.07. 004.
6. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L. Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 1995; 270:19173-80; PMID:7642585; http://dx.doi.org/10. 1074/jbc.270.32.19173.
7. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337-48; PMID:9590169; http://dx.doi.org/10.1016/S0092-8674(00)81163-0.
8. Westergard L, Turnbaugh JA, Harris DA. A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation. J Biol Chem 2011; 286:44234-42; PMID:22025612; http://dx.doi.org/10.1074/jbc.M111.286195.
9. Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, et al. Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci 2010; 13:310-8; PMID:20098419; http://dx.doi.org/10.1038/nn.2483.
10. Guillot-Sestier MV, Sunyach C, Druon C, Scarzello S, Checler F. The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J Biol Chem 2009; 284:35973-86; PMID:19850936; http://dx.doi.org/10.1074/jbc.M109.051086.
11. Guillot-Sestier MV, Sunyach C, Ferreira ST, Marzolo MP, Bauer C, Thevenet A, et al. The alpha-secretasederived fragment of cellular prion, N1, protects against monomeric and oligomeric Abeta-associated cell death. J Biol Chem 2011; PMID:22184125.
12. Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, et al. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem 2009; 284:22590-600; PMID:19564338; http://dx.doi.org/10.1074/jbc.M109.032599.
13. Alais S, Simoes S, Baas D, Lehmann S, Raposo G, Darlix JL, et al. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biol Cell 2008; 100:603-15; PMID:18422484; http://dx.doi.org/10.1042/ BC20080025.
14. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, et al. Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 2004; 101:9683-8; PMID:15210972; http://dx.doi.org/10.1073/pnas.0308413101.
15. Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 2007; 211:582-90; PMID:17334982; http://dx.doi.org/10.1002/ path.2145.
16. Liang J, Wang W, Sorensen D, Medina S, Ilchenko S, Kiselar J, et al. Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle. J Biol Chem 2012; 287:16510-20; PMID:22447932; http://dx.doi.org/10.1074/jbc.M112.360891.
17. Cissé MA, Sunyach C, Lefranc-Jullien S, Postina R, Vincent B, Checler F. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J Biol Chem 2005; 280:40624-31; PMID:16236709; http://dx.doi.org/10.1074/jbc.M506069200.
18. Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, et al. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 2001; 276:37743-6; PMID:11477090.
19. Altmeppen HC, Prox J, Puig B, Kluth MA, Bernreuther C, Thurm D, et al. Lack of a-disintegrin-and-metallo-proteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener 2011; 6:36; PMID:21619641; http://dx.doi.org/10.1186/1750-1326-6- 36.
20. Endres K, Mitteregger G, Kojro E, Kretzschmar H, Fahrenholz F. Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Neurobiol Dis 2009; 36:233-41; PMID:19632330; http://dx.doi. org/10.1016/j.nbd.2009.07.015.
21. Harris DA, Huber MT, van Dijken P, Shyng SL, Chait BT, Wang R. Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry 1993; 32:1009-16; PMID:8093841; http://dx.doi.org/10.1021/ bi00055a003.
22. Oliveira-Martins JB, Yusa S, Calella AM, Bridel C, Baumann F, Dametto P, et al. Unexpected tolerance of alpha-cleavage of the prion protein to sequence variations. PLoS One 2010; 5:e9107; PMID:20161712; http://dx.doi.org/10.1371/ journal.pone.0009107.
23. Wegner C, Römer A, Schmalzbauer R, Lorenz H, Windl O, Kretzschmar HA. Mutant prion protein acquires resistance to protease in mouse neuroblastoma cells. J Gen Virol 2002; 83:1237-45; PMID:11961279.
24. Leblanc P, Alais S, Porto-Carreiro I, Lehmann S, Grassi J, Raposo G, et al. Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J 2006; 25:2674-85; PMID:16724107; http://dx.doi.org/10.1038/sj. emboj.7601162.
25. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006; Chapter 3:Unit 3 22.
26. Laffont-Proust I, Faucheux BA, Hässig R, Sazdovitch V, Simon S, Grassi J, et al. The N-terminal cleavage of cellular prion protein in the human brain. FEBS Lett 2005; 579:6333-7; PMID:16263114; http://dx.doi.org/10.1016/j. febslet.2005.10.013.
27. Shyng SL, Huber MT, Harris DA. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 1993; 268:15922-8; PMID:8101844.
28. Turnbaugh JA, Westergard L, Unterberger U, Biasini E, Harris DA. The N-terminal, polybasic region is critical for prion protein neuroprotective activity. PLoS One 2011; 6:e25675; PMID:21980526; http://dx.doi.org/10.1371/ journal.pone.0025675.
29. Jiménez-Huete A, Lievens PM, Vidal R, Piccardo P, Ghetti B, Tagliavini F, et al. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol 1998; 153:1561-72; PMID:9811348; http://dx.doi.org/10.1016/ S0002-9440(10)65744-6.
30. Yadavalli R, Guttmann RP, Seward T, Centers AP, Williamson RA, Telling GC. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation. J Biol Chem 2004; 279:21948- 56; PMID:15026410; http://dx.doi.org/10.1074/jbc.M400793200.
31. Liu T, Zwingman T, Li R, Pan T, Wong BS, Petersen RB, et al. Differential expression of cellular prion protein in mouse brain as detected with multiple anti-PrP monoclonal antibodies. Brain Res 2001; 896:118-29; PMID:11277980; http://dx.doi.org/10.1016/S0006-8993(01)02050-9.
32. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 1995; 129:121-32; PMID:7698979; http://dx.doi.org/10.1083/jcb.129.1.121.
33. Tveit H, Lund C, Olsen CM, Ersdal C, Prydz K, Harbitz I, et al. Proteolytic processing of the ovine prion protein in cell cultures. Biochem Biophys Res Commun 2005; 337:232-40; PMID:16182247; http://dx.doi.org/10.1016/j. bbrc.2005.09.031.
34. Walmsley AR, Watt NT, Taylor DR, Perera WS, Hooper NM. alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts. Mol Cell Neurosci 2009; 40:242-8; PMID:19056496; http://dx.doi.org/10.1016/j.mcn.2008.10.012.
35. Borchelt DR, Rogers M, Stahl N, Telling G, Prusiner SB. Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology 1993; 3:319-29; PMID:7691278; http://dx.doi.org/10.1093/glycob/3.4.319.
36. Parkin ET, Watt NT, Turner AJ, Hooper NM. Dual mechanisms for shedding of the cellular prion protein. J Biol Chem 2004; 279:11170-8; PMID:14711812; http://dx.doi.org/10.1074/jbc.M312105200.
37. Checler F, Vincent B. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci 2002; 25:616-20; PMID:12446128; http://dx.doi.org/10.1016/S0166-2236(02)02263-4.
38. Vincent B, Paitel E, Frobert Y, Lehmann S, Grassi J, Checler F. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J Biol Chem 2000; 275:35612-6; PMID:10952979; http://dx.doi.org/10.1074/jbc.M004628200.
39. Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2:569-79; PMID:12154376.
40. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature 2005; 437:257-61; PMID:16148934; http://dx.doi.org/10.1038/nature03989.
41. Korth C, Stierli B, Streit P, Moser M, Schaller O, Fischer R, et al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 1997; 390:74-7; PMID:9363892; http://dx.doi.org/10.1038/36337.
42. Langeveld JP, Jacobs JG, Erkens JH, Bossers A, van Zijderveld FG, van Keulen LJ. Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep. BMC Vet Res 2006; 2:19; PMID:16764717; http://dx.doi.org/10.1186/1746-6148-2-19.
43. Vorberg I, Buschmann A, Harmeyer S, Saalmüller A, Pfaff E, Groschup MH. A novel epitope for the specific detection of exogenous prion proteins in transgenic mice and transfected murine cell lines. Virology 1999; 255:26-31; PMID:10049818; http://dx.doi.org/10.1006/viro.1998.9561.